Back to Search
Start Over
Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.
- Source :
-
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2017 Jun; Vol. 12 (2), pp. 260-276. Date of Electronic Publication: 2016 Sep 17. - Publication Year :
- 2017
-
Abstract
- Potassium voltage-gated Kv1.6 channel, which is distributed primarily in neurons of central and peripheral nervous systems, is of significant physiological importance. To date, several high-affinity Kv1.6-channel blockers are known, but the lack of selective ones among them hampers the studies of tissue localization and functioning of Kv1.6 channels. Here we present an approach to advanced understanding of interactions of peptide toxin blockers with a Kv1.6 pore. It combines molecular modeling studies and an application of a new bioengineering system based on a KcsA-Kv1.6 hybrid channel for the quantitative fluorescent analysis of blocker-channel interactions. Using this system we demonstrate that peptide toxins agitoxin 2, kaliotoxin1 and OSK1 have similar high affinity to the extracellular vestibule of the K <superscript>+</superscript> -conducting pore of Kv1.6, hetlaxin is a low-affinity ligand, whereas margatoxin and scyllatoxin do not bind to Kv1.6 pore. Binding of toxins to Kv1.6 pore has considerable inverse dependence on the ionic strength. Model structures of KcsA-Kv1.6 and Kv1.6 complexes with agitoxin 2, kaliotoxin 1 and OSK1 were obtained using homology modeling and molecular dynamics simulation. Interaction interfaces, which are formed by 15-19 toxin residues and 10 channel residues, are described and compared. Specific sites of Kv1.6 pore recognition are identified for targeting of peptide blockers. Analysis of interactions between agitoxin 2 derivatives with point mutations (S7K, S11G, L19S, R31G) and KcsA-Kv1.6 confirms reliability of the calculated complex structure.
- Subjects :
- Amino Acid Sequence
Bacterial Proteins chemistry
Bacterial Proteins genetics
Dose-Response Relationship, Drug
Humans
Kv1.6 Potassium Channel
Potassium Channel Blockers chemistry
Potassium Channel Blockers pharmacology
Potassium Channels chemistry
Potassium Channels genetics
Protein Binding physiology
Protein Structure, Secondary
Protein Structure, Tertiary
Shaker Superfamily of Potassium Channels chemistry
Shaker Superfamily of Potassium Channels genetics
Bacterial Proteins antagonists & inhibitors
Bacterial Proteins metabolism
Models, Molecular
Potassium Channel Blockers metabolism
Potassium Channels metabolism
Shaker Superfamily of Potassium Channels antagonists & inhibitors
Shaker Superfamily of Potassium Channels metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1557-1904
- Volume :
- 12
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 27640211
- Full Text :
- https://doi.org/10.1007/s11481-016-9710-9